These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25015681)

  • 21. Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis.
    Briongos-Figuero S; Estévez A; Luisa Pérez M; Martínez-Ferrer JB; García E; Viñolas X; Arenal Á; Alzueta J; Basterra N; Rodríguez A; Lozano I; Muñoz-Aguilera R
    Int J Cardiol; 2019 Jan; 274():163-169. PubMed ID: 30206014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac 123I-MIBG scintigraphy in heart failure.
    Agostini D; Verberne HJ; Hamon M; Jacobson AF; Manrique A
    Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):369-77. PubMed ID: 19088691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship of left ventricular mechanical dyssynchrony and cardiac sympathetic denervation to potential sudden cardiac death events in systolic heart failure.
    Hage FG; Aggarwal H; Patel K; Chen J; Jacobson AF; Heo J; Ahmed A; Iskandrian AE
    J Nucl Cardiol; 2014 Feb; 21(1):78-85. PubMed ID: 24170623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional Cardiac Sympathetic Nervous System Evaluation Using 123I-mIBG SPECT in Patients with Heart Failure.
    Iqbal B; Currie G; Kiat H
    J Med Imaging Radiat Sci; 2018 Dec; 49(4):397-405. PubMed ID: 30514557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy.
    Gold MR; Ip JH; Costantini O; Poole JE; McNulty S; Mark DB; Lee KL; Bardy GH
    Circulation; 2008 Nov; 118(20):2022-8. PubMed ID: 18955671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial
    Verschure DO; Lutter R; van Eck-Smit BLF; Somsen GA; Verberne HJ
    J Nucl Cardiol; 2018 Jun; 25(3):845-853. PubMed ID: 27858345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired cardiac sympathetic innervation and myocardial perfusion are related to lethal arrhythmia: quantification of cardiac tracers in patients with ICDs.
    Nishisato K; Hashimoto A; Nakata T; Doi T; Yamamoto H; Nagahara D; Shimoshige S; Yuda S; Tsuchihashi K; Shimamoto K
    J Nucl Med; 2010 Aug; 51(8):1241-9. PubMed ID: 20679471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ECG quantification of myocardial scar and risk stratification in MADIT-II.
    Loring Z; Zareba W; McNitt S; Strauss DG; Wagner GS; Daubert JP
    Ann Noninvasive Electrocardiol; 2013 Sep; 18(5):427-35. PubMed ID: 24047486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence of
    Piña IL; Carson P; Lindenfeld J; Archambault WT; Jacobson AF
    Am J Cardiol; 2017 Feb; 119(3):434-439. PubMed ID: 27912890
    [No Abstract]   [Full Text] [Related]  

  • 30. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study.
    Agostini D; Verberne HJ; Burchert W; Knuuti J; Povinec P; Sambuceti G; Unlu M; Estorch M; Banerjee G; Jacobson AF
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):535-46. PubMed ID: 18043919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Added Value of 3- Versus 2-Dimensional Echocardiography Left Ventricular Ejection Fraction to Predict Arrhythmic Risk in Patients With Left Ventricular Dysfunction.
    Rodríguez-Zanella H; Muraru D; Secco E; Boccalini F; Azzolina D; Aruta P; Surkova E; Genovese D; Cavalli G; Sammarco G; Ruozi N; Tenaglia RM; Calvillo-Argüelles O; Palermo C; Iliceto S; Badano LP
    JACC Cardiovasc Imaging; 2019 Oct; 12(10):1917-1926. PubMed ID: 30219408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy.
    Gulati A; Jabbour A; Ismail TF; Guha K; Khwaja J; Raza S; Morarji K; Brown TD; Ismail NA; Dweck MR; Di Pietro E; Roughton M; Wage R; Daryani Y; O'Hanlon R; Sheppard MN; Alpendurada F; Lyon AR; Cook SA; Cowie MR; Assomull RG; Pennell DJ; Prasad SK
    JAMA; 2013 Mar; 309(9):896-908. PubMed ID: 23462786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
    Kasama S; Toyama T; Sumino H; Nakazawa M; Matsumoto N; Sato Y; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2008 Jun; 49(6):907-14. PubMed ID: 18483106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-Effectiveness Analysis of Iodine-123 Meta-Iodobenzylguanidine Imaging for Screening Heart Failure Patients Eligible for an Implantable Cardioverter Defibrillator in the USA.
    O'Day K; Levy WC; Johnson M; Jacobson AF
    Appl Health Econ Health Policy; 2016 Jun; 14(3):361-73. PubMed ID: 26975999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac sympathetic innervation and mortality risk scores in patients with heart failure.
    Bencivenga L; Komici K; Paolillo S; Nappi C; Gargiulo P; Assante R; Gambino G; Santillo F; Femminella GD; Corbi GM; Ferrara N; Cuocolo A; Perrone-Filardi P; Rengo G
    Eur J Clin Invest; 2023 Mar; 53(3):e13948. PubMed ID: 36576359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of cardiac metaiodobenzylguanidine imaging and QRS duration in implantable cardioverter defibrillator patients with and without heart failure.
    Kawasaki M; Yamada T; Morita T; Furukawa Y; Tamaki S; Iwasaki Y; Kikuchi A; Kawai T; Seo M; Hirota Kida ; Sakata Y; Fukunami M
    Int J Cardiol; 2019 Dec; 296():164-171. PubMed ID: 31371118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of cardiac meta-iodobenzylguanidine imaging to identify patients with chronic heart failure and left ventricular ejection fraction <35% at low risk for sudden cardiac death.
    Kawai T; Yamada T; Tamaki S; Morita T; Furukawa Y; Iwasaki Y; Kawasaki M; Kikuchi A; Kondo T; Takahashi S; Ishimi M; Hakui H; Ozaki T; Sato Y; Seo M; Sakata Y; Fukunami M
    Am J Cardiol; 2015 Jun; 115(11):1549-54. PubMed ID: 25851796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic prognostic implications of left ventricular mechanical dyssynchrony and impaired cardiac sympathetic nerve activity in heart failure patients with reduced left ventricular ejection fraction.
    Doi T; Nakata T; Yuda S; Hashimoto A
    Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):74-83. PubMed ID: 28158459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.
    Au-Yeung WT; Reinhall PG; Poole JE; Anderson J; Johnson G; Fletcher RD; Moore HJ; Mark DB; Lee KL; Bardy GH
    Heart Rhythm; 2015 Oct; 12(10):2058-66. PubMed ID: 26096609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.